Aptadel Therapeutics has secured $500,000 from a US-based Children’s Foundation: Little Warrior Foundation

Aptadel Therapeutics has secured $500,000 from a US-based Children’s Foundation, Little Warrior Foundation, to support its Ewing Sarcoma therapeutic program.

Little Warrior’s decision to fund APTADEL reflects their commitment to supporting breakthrough solutions for childhood cancer, which remains one of the leading causes of death among children globally. We celebrate this milestone as a step forward in our mission to exploit RNA technologies in pediatric oncology, pushing the boundaries of cancer research while forging additional partnerships to expand its impact.

Read the full article at: https://www.expansion.com/catalunya/2025/01/21/678fed2c468aeb9f478b45ad.html